Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishe pill for postoperative symptoms of cervical spondylotic myelopathy
ChiCTR1900028173Phase 4Recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Qishe Pill and mecobalamin in cervical spondylomyelopathy (CSM) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Visual Analog Scale, Japanese Orthopaedic Association score for cervical spine and 1 more. Started Dec 2019; status: recruiting.
02
Drugs
Qishe Pillmecobalamin
03
Conditions
cervical spondylomyelopathy (CSM)
Beyond the preview
Go deeper on ChiCTR1900028173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028173.